ABCG2 and neoplasm: Moreover, the oral administration of 30 mg/kg of VKNG-1 with irinotecan (10 mg/kg i.p.)remarkably attenuated the tumor growth in mice implanted with ABCG2 overexpressing S1-M1-80 mouse xenografts.